System1 Biosciences raises $25M in Series A round for neurotherapeutics discovery platform
System1 Biosciences' platform combines stem cell lines from patients with brain diseases with a three-dimensional in vitro system and data analytics.
GW Pharmaceuticals gets first FDA approval for CBD-based drug
The FDA approved the cannabis-based drug for treating seizures in two severe forms of epilepsy.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Start-up plans to target epilepsy using gut microbiota
Bloom Science plans to have its proprietary gut bacteria in the clinic for hard-to-treat patients in the next 12-18 months.
A wearable using AI to identify severe seizures and warn caregivers gains FDA approval
By passively collecting seizure data, Empatica's device could help patients share medical information with clinicians and make that data easier to manage.
Blackfynn gets $2.3M, adds partners for data integration tools to accelerate neuroscience research
Medical researchers frequently spend the majority of their time formatting research data and 10 percent of their time actually using it. Blackfynn hopes its platform will aid translational research and therapeutic product development.
This entrepreneur’s device is designed to protect the tongue during a seizure
NeuroVice's device is designed to provide a safe way to protect tongues and minimize salivation during seizures.
The Impact Brands: Empowering Wellness Through Natural and Holistic Solutions
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
Smart watches are opening up seizure tracking (Updated)
The goal is to track the severity and length of the seizure using sensors such as an accelerometer and a gyroscope as well as a memory test when the user comes out of the event.
Aprecia Pharmaceuticals brings in $35M to move forward with 3D printed dissolving drug pipeline
Aprecia Pharmaceuticals is getting closer to commercializing SPRITAM, its 3D printed formulation of levetiracetam, which is a well-established medication used by patients with epilepsy.
Convenient timing, Shkreli: Turing’s epilepsy drug gets fast-tracked by FDA
The day after news broke that Turing Pharmaceuticals' Daraprim has a new competitor on the market, CEO Martin Shkreli announced the company's gotten fast-track status for its experimental epilepsy drug.
Turing announces first IND application for new brain disorder drug (post-Daraprim pricing controversy)
Turing isn't just buying drugs and bumping up prices. It is actually putting a focus on new drugs, which is exemplified with its recent investigational new drug application.
Using Informed Awareness to Transform Care Coordination and Improve the Clinical and Patient Experience
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
Epilepsy device developer NeuroSigma has withdrawn its $50M IPO plans
The Los Angeles-based company developing its drug-resistant epilepsy system has officially backed out of its IPO plans.
Wearables help manage neurological disorders, predict symptoms
New, wearable technology not only helps monitor symptoms automatically, it may be able to predict seizures and disease progression in patients with neurological disorders.
FDA approved first 3D printed drug. What are other applications for this technology?
The FDA just approved the first 3D printed drug. Are there other applications for this technology?
Morning Read: FDA approves the first 3D printed drug, OraSure Ebola test gets FDA Emergency Use Authorization
The FDA has approved a 3D-printed drug designed to treat epileptics, OraSure Technologies' Ebola test gets emergency use authorization.
Implantable brain device could restore lost memories, help create new ones
Here’s a story with a slight Cyborg ring to it: An implantable brain device that can potentially restore the memory of patients with traumatic brain injury, Alzheimer’s disease, epilepsy and related conditions is being developed at the government’s Lawrence Livermore National Laboratory. The technology sits at the nexus of human, neuron-based memory and digital, computer chip-based memory: The device […]